BR0211066A - produção de células progenitoras hematopoiéticas transduzidas - Google Patents

produção de células progenitoras hematopoiéticas transduzidas

Info

Publication number
BR0211066A
BR0211066A BRPI0211066-0A BR0211066A BR0211066A BR 0211066 A BR0211066 A BR 0211066A BR 0211066 A BR0211066 A BR 0211066A BR 0211066 A BR0211066 A BR 0211066A
Authority
BR
Brazil
Prior art keywords
progenitor cells
production
hematopoietic progenitor
transduced hematopoietic
transduced
Prior art date
Application number
BRPI0211066-0A
Other languages
English (en)
Inventor
John Murray
Greg Fanning
Janet Macpherson
Susan Pond
Geoffrey Symonds
Original Assignee
Johnson & Johnson Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Res Pty Ltd filed Critical Johnson & Johnson Res Pty Ltd
Publication of BR0211066A publication Critical patent/BR0211066A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

"PRODUçãO DE CéLULAS PROGENITORAS HEMATOPOIéTICAS TRANSDUZIDAS". A presente invenção refere-se à um método para introduzir células progenitoras hematopoieticas contendo ácido nucléico exógeno em um paciente.
BRPI0211066-0A 2001-07-10 2002-07-10 produção de células progenitoras hematopoiéticas transduzidas BR0211066A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30428301P 2001-07-10 2001-07-10
US34339201P 2001-10-22 2001-10-22
PCT/US2002/021713 WO2003006612A2 (en) 2001-07-10 2002-07-10 Production of transduced hematopoietic progenitor cells

Publications (1)

Publication Number Publication Date
BR0211066A true BR0211066A (pt) 2006-08-29

Family

ID=26973926

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0211066-0A BR0211066A (pt) 2001-07-10 2002-07-10 produção de células progenitoras hematopoiéticas transduzidas

Country Status (9)

Country Link
US (1) US20030082158A1 (pt)
EP (1) EP1418814A4 (pt)
JP (1) JP2005521632A (pt)
KR (1) KR20040084885A (pt)
CN (1) CN1551728A (pt)
BR (1) BR0211066A (pt)
CA (1) CA2453187A1 (pt)
IL (1) IL159777A0 (pt)
WO (1) WO2003006612A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020058636A1 (en) * 1994-09-21 2002-05-16 Geoffrey P. Symonds Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
US7994144B2 (en) 2001-07-10 2011-08-09 Johnson & Johnson Research Pty, Limited Process for the preparation of a composition of genetically modified hematopoietic progenitor cells
CN101926824A (zh) 2001-07-10 2010-12-29 强生和强生研究有限公司 用于遗传修饰造血祖细胞的方法和这些被修饰细胞的应用
US7799324B2 (en) 2001-12-07 2010-09-21 Geron Corporation Using undifferentiated embryonic stem cells to control the immune system
EP2292734A1 (en) * 2001-12-07 2011-03-09 Geron Corporation Hematopoietic cells from human embryonic stem cells
AU2003294029A1 (en) * 2002-11-06 2004-06-07 L'oreal Composition containing a semi-crystalline polymer and a pasty fatty substance
FR2846554B1 (fr) * 2002-11-06 2007-02-09 Oreal Composition contenant un polymere semi-cristallin et un corps gras pateux
GB0410130D0 (en) * 2004-05-06 2004-06-09 Molmed Spa Cell preparation
WO2012074068A1 (ja) 2010-12-01 2012-06-07 日産化学工業株式会社 ピラゾール化合物による造血幹細胞の製造方法
US11697799B2 (en) 2019-04-15 2023-07-11 Ossium Health, Inc. System and method for extraction and cryopreservation of bone marrow
EP4181675A4 (en) 2020-07-18 2024-04-24 Ossium Health Inc PERMEATION OF WHOLE VERTEBRAL BODY WITH CRYOPROTECTIVE USING VACUUM-ASSISTED DIFFUSION
WO2022081909A1 (en) 2020-10-14 2022-04-21 Ossium Health, Inc. Systems and methods for extraction and cryopreservation of bone marrow
EP4262831A1 (en) 2020-12-18 2023-10-25 Ossium Health, Inc. Methods of cell therapies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500357A (en) * 1990-11-02 1996-03-19 Agency Of Industrial Science & Technology, Ministry Of International Trade & Industry RNA transcription system using novel ribozyme
US5693535A (en) * 1992-05-14 1997-12-02 Ribozyme Pharmaceuticals, Inc. HIV targeted ribozymes
US5525468A (en) * 1992-05-14 1996-06-11 Ribozyme Pharmaceuticals, Inc. Assay for Ribozyme target site
US5911983A (en) * 1992-06-26 1999-06-15 University Of Pittsburgh Gene therapy for Gaucher disease using retroviral vectors
US5712384A (en) * 1994-01-05 1998-01-27 Gene Shears Pty Ltd. Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
US20020058636A1 (en) * 1994-09-21 2002-05-16 Geoffrey P. Symonds Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
CN101926824A (zh) * 2001-07-10 2010-12-29 强生和强生研究有限公司 用于遗传修饰造血祖细胞的方法和这些被修饰细胞的应用
US7994144B2 (en) * 2001-07-10 2011-08-09 Johnson & Johnson Research Pty, Limited Process for the preparation of a composition of genetically modified hematopoietic progenitor cells

Also Published As

Publication number Publication date
JP2005521632A (ja) 2005-07-21
CN1551728A (zh) 2004-12-01
WO2003006612A3 (en) 2003-09-12
CA2453187A1 (en) 2003-01-23
EP1418814A4 (en) 2006-10-11
IL159777A0 (en) 2004-06-20
WO2003006612A2 (en) 2003-01-23
EP1418814A2 (en) 2004-05-19
KR20040084885A (ko) 2004-10-06
US20030082158A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
BR0211066A (pt) produção de células progenitoras hematopoiéticas transduzidas
BR0010806A (pt) Métodos e materiais para a sìntese de produtos orgânicos
DK1082293T3 (da) Formoterol-polymorfer
DE60232773D1 (de) Verfahren zur Herstellung von Membran-Elektrode-Anordnungen für Brennstoffzellen
ECSP034460A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos
DE60231708D1 (de) Somatische pluripotente Zellen
DE60110497D1 (de) Verfahren zur Herstellung von Acrylsäure
DE69802443D1 (de) Verfahren zur Herstellung reiner Alkansulfonsäure
EE03955B1 (et) Nukleiinhappe kasutamine ravimi valmistamiseks imetaja reproduktiivtrakti vähemalt mõne raku transfekteerimiseks
BR0317005A (pt) Processo para a preparação de compostos ativos opticamente puros
BR0115036A (pt) Processo para a preparação de um composto
DE60229194D1 (de) Verfahren zur Herstellung von Acrylsäure
DE69524103T2 (de) Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen
BR0111188A (pt) Inibidores de adesão de célula mediada por alfal beta2
DE50113943D1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
BR9809626A (pt) Compostos à base de compostos de polialquil-1-oxa-diazaespiro-decano
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
DE60228724D1 (de) Verfahren zur herstellung von beraprost und dessen salzen
TR200503401T1 (tr) Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BR0212390A (pt) Processo para a preparação de cilastatina
BR0009518A (pt) Processo para a preparação de um éster do ácido 2-hidroxi-4-metiltiobutìrico
BR0001342A (pt) Processo para a produção de l-aminoácidos por meio de fermentação usando bactérias corineformes
ITMI20002187A0 (it) Processo per la produzione dell'acido r(+) -lipico
DE69812438D1 (de) Zusammensetzung zur herstellung von brennstoff-briketts

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2060 DE 29/06/2010.

B15K Others concerning applications: alteration of classification

Ipc: C12N 5/0789 (2010.01), A61K 48/00 (2006.01), A61K